|
Dr. Mohrland, President and CEO of Erimos, has extensive experience in the pharmaceutical industry building and managing global organizations focused on the development and commercialization of oncology and other therapeutic products. Before joining Erimos, Dr. Mohrland served as Executive Vice President for GMP Companies, Inc., a global company focused on the development and commercialization of pharmaceuticals and other medical products. Prior to GMP, he spent more than 21 years with Pharmacia Corporation, Pharmacia and Upjohn, Inc. and the Upjohn Company, where he held a number of executive positions, including Vice President of Scientific, Professional and Government Operations, and Vice President of Medical Operations and Scientific Affairs. Dr. Mohrland has served on several boards, including serving as Vice Chairman of Florida’s biotechnology industry organization. He has held several academic appointments at major universities. Dr. Mohrland received his PhD in pharmacology from Washington State University, and was a Postdoctoral Fellow at the University of Iowa. He has authored numerous scientific and medical publications and been a member of several scientific and medical societies. | 